Table 6.
Management Strategies for Common Adverse Effects of LAIs
| Adverse effect | Management strategies |
|---|---|
| Drug-induced Parkinsonism (DIP) | Reduce LAI dose; switch to lower-risk antipsychotic (clozapine, quetiapine); add amantadine; consider anticholinergic (short-term) |
| Sedation | Reduce dose if possible; switch to less-sedating antipsychotic (aripiprazole, paliperidone) |
| Insomnia | Optimize timing of concomitant medications; sleep hygiene training; CBT-I; consider short-term hypnotic |
| Clinical evidence of prolactin elevation | Reduce LAI dose; switch to prolactin-sparing antipsychotic (aripiprazole, olanzapine); add adjunctive aripiprazole |
| Akathisia | Reduce LAI dose; switch to lower-risk antipsychotic; use adjunctive medication (vitamin B6, mirtazapine, or an anticholinergic) until dose reduction or switching LAI is completed |
| Injection site reactions | Local symptomatic treatment (ice, heat, or topical steroid); proper injection technique (site rotation, needle size); avoid massaging injection site |